Physicians' Academy
for Cardiovascular Education
Agenda
Topics
▼
Media
▼
Online-CME
News
▼
Meeting Reports
Slides
▼
About
ACC 2020
▼
AHA 2020
▼
Covid-19
▼
Diabetes & CVD
▼
ESC 2020
▼
HF Practical Tutorials
▼
Kidney disease & CVD
▼
LDL cholesterol, LDL receptor & PCSK9
3' education - July 31, 2013
A mechanism of action animation on the potential role of the inhibition of PCSK9 with a monoclonal antibody.
Provided as an educational service by Regeneron /Sanofi
Share this page with your colleagues and friends:
Share this page with your colleagues and friends: